| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/11/2000 | US6087003 Method of coating particles and coated spherical particles |
| 07/11/2000 | US6086924 Skin care composition |
| 07/11/2000 | US6086918 Releasing peptide active agent, with ph lowering agent and an absorption enhancer into patient's intestine through mouth and stomach under protection of an acid resistant vehicle which prevents contact between stomach protease and peptide |
| 07/11/2000 | US6086900 Cells and conjugated molecules |
| 07/11/2000 | US6086899 Ethylene oxide-propylene oxide copolymer |
| 07/11/2000 | US6086875 Receptor specific transepithelial transport of immunogens |
| 07/11/2000 | US6086863 Compositions of microspheres for wound healing |
| 07/11/2000 | US6086597 Ophthalmic composition |
| 07/11/2000 | US6086376 Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant |
| 07/11/2000 | CA2188385C Dosage forms and method for ameliorating male erectile dysfunction |
| 07/06/2000 | WO2000039290A2 Pharmaceutical formulation containing a microbial enzyme which digests hyaluronic acid |
| 07/06/2000 | WO2000039285A2 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof |
| 07/06/2000 | WO2000039176A1 Hydrophilic ampholytic polymer |
| 07/06/2000 | WO2000039159A1 Superantigens |
| 07/06/2000 | WO2000039155A1 PENICILLINS AS PHARMACEUTICALS FOR THE DOWNREGULATION OF IFNη PRODUCTION |
| 07/06/2000 | WO2000039070A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | WO2000038811A1 Apparatus and process for preparing crystalline particles |
| 07/06/2000 | WO2000038747A2 Absorbent article composition and method of use for sequestering skin irritants |
| 07/06/2000 | WO2000038736A1 Medicinal preparations |
| 07/06/2000 | WO2000038735A1 Pharmaceutical preparation |
| 07/06/2000 | WO2000038734A1 Anthraquinone anticancer drugs |
| 07/06/2000 | WO2000038733A1 Peptidic product, process and composition |
| 07/06/2000 | WO2000038732A1 Hyaluronate lyase used for promoting penetration in topical agents |
| 07/06/2000 | WO2000038731A1 External preparation |
| 07/06/2000 | WO2000038710A2 Dual hapten modified tumor cells and tumor polypeptides and methods of treating cancer |
| 07/06/2000 | WO2000038702A1 Cyclosporin solution |
| 07/06/2000 | WO2000038696A1 Cyanocobalamin (vitamin b12) treatment in allergic disease |
| 07/06/2000 | WO2000038695A2 Aciclovir compositions containing dimethicone |
| 07/06/2000 | WO2000038686A1 Controlled release galantamine composition |
| 07/06/2000 | WO2000038681A1 Liposomic niflumic acid - new transdermal anti-inflammatory medicine |
| 07/06/2000 | WO2000038676A1 Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors |
| 07/06/2000 | WO2000038672A2 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 07/06/2000 | WO2000038659A1 Transdermal drug delivery system |
| 07/06/2000 | WO2000038658A1 Spray-type cosmetic composition and matrix used in said composition for dermal administration |
| 07/06/2000 | WO2000038657A1 Method for preparing an effervescent granulate comprising iron gluconate, granulate thus obtained and tablets containing the same |
| 07/06/2000 | WO2000038655A1 Dosage forms comprising porous particles |
| 07/06/2000 | WO2000038653A1 Improved formulation for topical non-invasive application in vivo |
| 07/06/2000 | WO2000038652A1 Polyol/oil suspensions for the sustained release of proteins |
| 07/06/2000 | WO2000038651A1 BIODEGRADABLE pH/THERMOSENSITIVE HYDROGELS FOR SUSTAINED DELIVERY OF BIOLOGICALLY ACTIVE AGENTS |
| 07/06/2000 | WO2000038647A1 Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis |
| 07/06/2000 | WO2000038646A1 Dermatological compositions containing tannic acid and a microbial proliferation inhibitor |
| 07/06/2000 | WO2000038644A1 Stable solution of zinc ions and bicarbonate and/or carbonate ions |
| 07/06/2000 | WO2000038626A2 Substrate composition and method of use for sequestration of skin irritants |
| 07/06/2000 | WO2000038625A2 Facial tissue composition and method of use for sequestration of nasal secretion skin irritants |
| 07/06/2000 | WO2000038515A1 Peptide mimics useful for treating disease |
| 07/06/2000 | WO2000018331A3 Drug delivery systems |
| 07/06/2000 | WO2000013686A3 Sustained release ranolazine formulations |
| 07/06/2000 | WO2000008467A3 Treatment of bacterial infections |
| 07/06/2000 | WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 07/06/2000 | WO1999055383A3 Improvements in or relating to diagnostic/therapeutic agents |
| 07/06/2000 | DE19900054A1 Taxane enthaltende stabile und sterile Emulsion und Verfahren zu ihrer Herstellung Taxanes containing sterile and stable emulsion and process for their preparation |
| 07/06/2000 | CA2358315A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | CA2358168A1 Ph responsive pharmaceutical preparation releasing a compound having a free amino group |
| 07/06/2000 | CA2357765A1 Liposomic niflumic acid - new transdermal anti-inflammatory medicine |
| 07/06/2000 | CA2356897A1 Apparatus and process for preparing crystalline particles |
| 07/06/2000 | CA2356895A1 Aciclovir compositions containing dimethicone |
| 07/06/2000 | CA2356755A1 Superantigens |
| 07/06/2000 | CA2356692A1 Hydrophilic ampholytic polymer |
| 07/06/2000 | CA2356399A1 Anthraquinone anticancer drugs |
| 07/06/2000 | CA2356186A1 Penicillins as pharmaceuticals for the downregulation of ifn.gamma. production |
| 07/06/2000 | CA2355872A1 Method for preparing an effervescent granulate comprising iron gluconate, granulate thus obtained and tablets containing the same |
| 07/06/2000 | CA2355468A1 Glycosyl phosphatidy linositol specific phospholipase d proteins and uses thereof |
| 07/06/2000 | CA2355271A1 Cyclosporin solution |
| 07/06/2000 | CA2351357A1 Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors |
| 07/06/2000 | CA2350685A1 Spray-type cosmetic composition and matrix used in said composition for dermal administration |
| 07/06/2000 | CA2334958A1 Peptide mimics useful for treating disease |
| 07/06/2000 | CA2318356A1 Pharmaceutical formulation containing a hyaluronic acid-splitting enzyme of microbial origin |
| 07/05/2000 | EP1016673A1 Composition comprising coagulation factor VIII formulation, process for its preparation and use of a surfactant as stabilizer |
| 07/05/2000 | EP1016453A1 Nanoemulsion based on ethoxylated fatty ethers or ethoxylated fatty esters and uses thereof in the fields of cosmetics, dermatology and/or ophthalmology |
| 07/05/2000 | EP1016417A1 Pressure-sensitive adhesives for percutaneous plasters and percutaneous plasters |
| 07/05/2000 | EP1016409A1 Freeze-dried composition containing glycosphingolipid and process for producing the same |
| 07/05/2000 | EP1016404A1 Aqueous preparation of beta-carotene |
| 07/05/2000 | EP1015884A1 Methods of identifying molecules that home to angiogenic vasculature in tumors |
| 07/05/2000 | EP1015585A2 Tie ligand homologues |
| 07/05/2000 | EP1015561A1 In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps) |
| 07/05/2000 | EP1015496A2 Immuntoxins and methods of inducing immune tolerance |
| 07/05/2000 | EP1015493A1 Novel epithelial tissue targeting agent |
| 07/05/2000 | EP1015490A1 No-modified hemoglobins and uses therefor |
| 07/05/2000 | EP1015046A2 Microdisperse drug delivery systems |
| 07/05/2000 | EP1015033A2 Substituted perylenequinones for use in photodynamic therapy |
| 07/05/2000 | EP1015032A2 High viscosity liquid controlled delivery system as a device |
| 07/05/2000 | EP1015028A2 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 07/05/2000 | EP1015027A2 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this procedure |
| 07/05/2000 | EP1015026A2 Il-12 as an adjuvant for bordetella pertussis vaccines |
| 07/05/2000 | EP1015022A1 New improved formulation for treatment of thromboembolism |
| 07/05/2000 | EP1015008A1 Compounds and compositions for delivering active agents |
| 07/05/2000 | EP1014961A1 Improved treatment of migraine headache |
| 07/05/2000 | EP1014954A2 Transdermal therapeutic system |
| 07/05/2000 | EP1014953A2 Formulations for hydrophobic pharmaceutical agents |
| 07/05/2000 | EP1014952A1 Multiple unit effervescent dosage form |
| 07/05/2000 | EP1014950A1 Dosage forms exhibiting multiphasic release kinetics and methods of manufacture thereof |
| 07/05/2000 | EP1014949A1 Rapidly disintegrating methylcellulose tablets |
| 07/05/2000 | EP1014948A1 Freeze-dried placebo pharmaceutical composition designed to imitate a medicine, in particular based on proteins or polypeptides |
| 07/05/2000 | EP1014945A1 Cationic lipid compositions targeting angiogenic endothelial cells |
| 07/05/2000 | EP1014944A2 Biocompatible compounds for pharmaceutical drug delivery systems |
| 07/05/2000 | EP1014943A1 Medical aerosol formulations |
| 07/05/2000 | EP1014942A1 Non-steroidal antiinflammatory drug formulations for topical application to the skin |
| 07/05/2000 | EP1014940A1 Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent |
| 07/05/2000 | EP1014926A1 Therapeutic and cosmetic compositions, their use and method for the preparation thereof |
| 07/05/2000 | EP1014804A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |